Shares of Moderna tumbled Monday after the vaccine maker predicted a steeper-than-expected sales drop in the new year. Moderna said it expects 2025 revenue to range between $1.5 billion and $2.5 ...
The Cambridge-based company said it expects 2025 revenue of between $1.5 billion to $2.5 billion, down from its previous ...
Moderna shares dropped as much as 22 per cent on Monday after the US biotech group’s sales forecasts disappointed investors.
Investor's Business Daily on MSN28m
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 GuidanceModerna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting ...
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting ...
Nvidia pushes back on new artificial-intelligence regulations, Moderna issues weak revenue guidance, and Intra-Cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback